Electromed (ELMD) Reports Q4 EPS of $0.11 on Revenues of $7.3M

Electromed (NYSE: ELMD) reported Q4 EPS of $0.11. Revenue for the quarter came in at $7.3 million.

Q4 FY 2017 Highlights

• Net revenue increased 27.8% to $7.3 million from $5.7 million during the three months ended June 30, 2016 (“Q4 FY 2016”). Net revenue for Q4 FY 2017 included a favorable impact of $703,000 from a one-time item, which is discussed further in the “Q4 FY 2017 Review” section.
• Gross profit rose 33.6% to $6.0 million from $4.5 million in Q4 FY 2016.
• Operating income grew 181.0% to $1.5 million from $539,000 in Q4 FY 2016.
• Net income expanded 180.7% to $946,000, or $0.11 per diluted share, from $337,000, or $0.04 per diluted share, in Q4 FY 2016.
• Field sales employees grew to 40 at the end of Q4 FY 2017 from 30 at the end of Q4 FY 2016.
• In June 2017, the Company launched SmartVest Connect™ wireless technology for SmartVest®SQL® as planned, with favorable feedback from pediatric and cystic fibrosis users and clinicians.

For earnings history and earnings-related data on Electromed (ELMD) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c